Corline Biomedical

Corline Biomedical Dividend

Dividend of Corline Biomedical (CLBIO.ST) as of Nov 11, 2026.

Dividend

0.00SEK

Last updated:

How much dividend does Corline Biomedical 2026 pay?

According to the latest status from November 2026, Corline Biomedical paid a total of 0.00 SEK per share in dividends within the last 12 months. With the current Corline Biomedical price of 13.40 SEK, this corresponds to a dividend yield of - %. A dividend is paid times per year.

Historical Corline Biomedical Dividends

Historical Corline Biomedical Dividends
PaydateDividend

The Corline Biomedical Dividend history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Date
Dividend
Jan 1, 2021
0.00 SEK
Jan 1, 2022
0.00 SEK
Jan 1, 2023
0.00 SEK
Jan 1, 2024
0.00 SEK
Jan 1, 2025
0.00 SEK
Jan 1, 2026 (e)
0.00 SEK
Jan 1, 2027 (e)
0.00 SEK
Jan 1, 2028 (e)
0.00 SEK
The Corline Biomedical Dividend history
YEARDividendYoY
est0.00SEK—
est0.00SEK—
est0.00SEK—
0.00SEK—
0.00SEK—
0.00SEK—
0.00SEK—
0.00SEK—
0.00SEK—
0.00SEK—
0.00SEK—
0.00SEK—
0.00SEK—
0.00SEK—
0.00SEK—
0.00SEK—
0.00SEK—

Is the Corline Biomedical Dividend Safe?

Corline Biomedical has been increasing the dividend for 0 years.

Analysts expect a Dividend Cut of -100.00% for the current fiscal year.

Dividend Details

Understanding Corline Biomedical's Dividend Distributions

Corline Biomedical’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Corline Biomedical's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Corline Biomedical's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Corline Biomedical’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Corline Biomedical Stock analysis

What does Corline Biomedical do? Corline Biomedical AB, headquartered in Uppsala, Sweden, operates in the Health Care sector, specifically within Pharmaceuticals. The company focuses on the research, development, and commercialization of heparin-based solutions for kidney transplantation, cell therapies, and regenerative medicine applications. Listed on 3 June 2015, Corline Biomedical employs eight people and is dedicated to advancing medical treatments through innovative heparin-based technologies. Corline Biomedical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Corline Biomedical stock

Corline Biomedical paid dividends every year for the past 0 years.

Corline Biomedical is assigned to the 'Health' sector.

The dividends of Corline Biomedical are distributed in SEK.

Dividend calendar 2026

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

All Key Metrics — Corline Biomedical